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ORIGINAL ARTICLE
Randomized, multi-center trial of two hypo-energetic
diets in obese subjects: high- versus low-fat content
M Petersen1,11, MA Taylor2,11, WHM Saris3, C Verdich4, S Toubro1, I Macdonald2, S Ro¨ssner5,
V Stich6, B Guy-Grand7, D Langin8, JA Martinez9, O Pedersen10, C Holst4, TIA Sørensen1,
A Astrup1 and The Nugenob Consortium12,13
1Institute of Human Nutrition, The Royal Veterinary and Agricultural University, Copenhagen, Denmark; 2School of
Biomedical Sciences, University of Nottingham Medical School, Queen’s Medical Centre, Nottingham, UK; 3Department of
Human Biology, Nutrition and Toxicology Research Centre NUTRIM, Maastricht University, Maastricht, The Netherlands;
4Institute of Preventive Medicine, Danish Epidemiology Science Centre, Copenhagen University Hospital, Copenhagen,
Denmark; 5The Obesity Unit, Department of Medicine, Karolinska Institute, Huddinge University Hospital, Sweden;
6Department of Sports Medicine, Centre of Preventive Medicine, Third Faculty of Medicine, Charles University, Praha, Czech
Republic; 7Department of Nutrition, Hoˆtel-Dieu, Paris, France; 8Obesity Research Unit Inserm U586, Louis Bugnard Institute
and Clinical Investigation Centre, Toulouse University Hospitals, Paul Sabatier University, Toulouse, France; 9Department
Physiology and Nutrition, University of Navarra, Pamplona, Spain and 10Steno Diabetes Centre, Gentofte, Denmark
Objective: To investigate whether a hypo-energetic low-fat diet is superior to a hypo-energetic high-fat diet for the treatment of
obesity.
Design: Open-label, 10-week dietary intervention comparing two hypo-energetic (600 kcal/day) diets with a fat energy
percent of 20–25 or 40–45.
Subjects: Obese (BMI X30 kg/m2) adult subjects (n¼771), from eight European centers.
Measurements: Body weight loss, dropout rates, proportion of subjects who lost more than 10% of initial body weight, blood
lipid profile, insulin and glucose.
Results: The dietary fat energy percent was 25% in the low-fat group and 40% in the high-fat group (mean difference: 16 (95%
confidence interval (CI) 15–17)%). Average weight loss was 6.9 kg in the low-fat group and 6.6 kg in the high-fat group (mean
difference: 0.3 (95% CI 0.2 to 0.8) kg). Dropout was 13.6% (n¼53) in the low-fat group and 18.3% (n¼70) in the high-fat
group (P¼ 0.001). Among completers, more subjects lost 410% in the low-fat group than in the high-fat group ((20.8%,
n¼70) versus (14.7%, n¼ 46), P¼0.02). Fasting plasma total, low-density lipoprotein- and high-density lipoprotein-cholesterol
decreased in both groups, but more so in the low-fat group than in the high-fat group. Fasting plasma insulin and glucose were
lowered equally by both diets.
Conclusions: The low-fat diet produced similar mean weight loss as the high-fat diet, but resulted in more subjects losing
410% of initial body weight and fewer dropouts. Both diets produced favorable changes in fasting blood lipids, insulin and
glucose.
International Journal of Obesity (2006) 30, 552–560. doi:10.1038/sj.ijo.0803186; published online 6 December 2005
Keywords: blood lipids; lipoprotein-cholesterol; drop-out rate; low-carbohydrate diet
Introduction
The rapidly increasing prevalence of obesity is a major,
global health problem because of the increased risk of serious
complications such as cardiovascular disease, type 2 diabetes
and some cancers.1 Even a minor weight loss of 4–6% in
obese individuals with impaired glucose tolerance is asso-
ciated with a reduction of the risk of type 2 diabetes by 58%
within 3–5 years.2,3
Successful weight loss depends upon achieving negative
energy balance, and the scientific debate regarding the
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optimal macronutrient composition for the dietary treat-
ment of obesity requires a better evidence-based fundament.
Meta-analyses of intervention trials have demonstrated that
ad libitum low-fat diets produce 3–4 kg weight loss over 3–6
months,4 and there is some evidence to suggest that weight
maintenance is easier to achieve by a fat-reduced diet than
with a higher fat diet.5 While there is little evidence to
support any important difference between low-fat diets with
complex and simple carbohydrates,6 higher protein levels
might improve weight loss.7 However, very few randomized
trials have been conducted, which combine energy restric-
tion and compare different levels of energy from fat and
carbohydrate. These studies have included only small
numbers of obese subjects and have therefore limited
statistical power to detect clinically relevant differences in
weight loss and body composition.8,9
Dietary composition also affects risk factors for cardio-
vascular disease and type 2 diabetes independently of weight
loss. Increasing the percentage of total energy from carbo-
hydrate while decreasing the percentage of energy from fat
may lower fasting plasma total and low-density lipoprotein
(LDL)-cholesterol and also high-density lipoprotein (HDL)-
cholesterol concentrations, and increase, at least initially,
fasting plasma triacylglycerol concentration.10,11 The same
changes in the diet induce a lowering of fasting plasma
insulin concentrations, reflecting an increase in whole-body
insulin sensitivity.12 However, it is less clear which diet
composition has the most beneficial effect during hypo-
energetic dieting.
The objective of this study was, in a randomized interven-
tion trial with obese subjects from eight centers in seven
European countries, to examine if a 10-week low-fat hypo-
energetic diet has a more beneficial effect on body weight,
body composition and concentrations of fasting plasma
lipids, glucose and insulin than a high-fat hypo-energetic diet.
Subjects and methods
Protocol
The study was a randomized, parallel, two-arm, open-label
10-week dietary intervention of two hypo-energetic diets at
eight sites in seven European countries: United Kingdom
(England), The Netherlands, France (two centers), Spain,
Czech Republic, Sweden and Denmark. The trial was part of a
study of gene–nutrient interactions in the physiology and
dietary treatment of obesity (see www.nugenob.org), in
which it was planned to recruit 100 subjects from each
center of the seven centers and 50 from one center. This
would allow the study to detect 0.7 kg difference in weight
loss, assuming a standard deviation (s.d.) of 4 kg, a
significance P-value of 0.05 and a statistical power of 0.90.
Participants
We included 771 Caucasian Europeans (579 women). Inclu-
sion criteria were body mass indexX30 kg/m2 and age 20–50
years. Exclusion criteria were weight change 43 kg within
the 3 months before the start of the study, hypertension,
diabetes or hyperlipidemia treated by drugs, untreated
thyroid disease, surgically or drug-treated obesity, pregnancy,
participation in other trials, alcohol or drug abuse. However,
some subjects were erroneously included despite a slightly
lower BMI, and slightly greater antecedent weight loss, but a
sensitivity analysis was conducted to examine the impor-
tance for the outcome (see statistical analysis). Analyses
evaluating whether excluding the subjects who either had an
inconsistent report of previous weight stability (n=82) or
failed to meet one or more of the inclusion criteria for body
mass index, fasting glucose, inconsistent bioimpedance
measurement, medication, menopausal status or race
(n=71) gave similar results, which are not presented.
Participants were recruited through the media, from waiting
lists, ongoing population studies, by self-referral or referral
from a general physician or other clinical units and local
obesity organizations. Recruitment of subjects was under-
taken from May 2001 until September 2002. The study was
approved by the Ethical Committee at each of the participat-
ing centers. Volunteers were informed about the nature of
the study, and written consent was obtained before study
participation.
Assignment
Stratified block randomization was used with center, gender
and three age groups (20–29, 30–39 and 40–50 years) as strata
and a block size of 12. The randomization list was computer
generated and the block size was unknown to the clinical
centers. Randomization was performed by contacting the
coordinating center at each allocation (see details at
www.nugenob.org).
Participant flow
The flow of participants is shown in Figure 1.
Randomized
N=771
Low-fat
N=389
High-fat
N=382
Dropouts
N=70
Dropouts
N=53
Completers
N=336
Completers
N=312
Figure 1 Flow chart describing the progress of participants throughout the
trial.
NUGENOB low- versus high-fat diet
M Petersen et al
553
International Journal of Obesity
Diets
The target macronutrient composition of the two diets was
as follows: low-fat diet – 20–25% of total energy from fat,
15% from protein and 60–65% from carbohydrate; high-fat
diet – 40–45% of total energy from fat, 15% from protein
and 40–45% from carbohydrate. Both diets were designed
to provide 600 kcal/day (1 kilocalorie (kcal)¼ 4.2 kilo joule
(kJ)) less than the individually estimated energy require-
ment based on an initial resting metabolic rate multiplied
by 1.3. Subjects were given oral and written instructions
relating to these targets based on either a template (see
details at www.nugenob.org) or an exchange system.13
Instructions were also given to minimize differences
between the two diets in other components such as sources
and type of fat, amount and type of fiber, type of
carbohydrate, fruit and vegetables, and meal frequency.
Subjects were requested to abstain from alcohol consump-
tion. Dietary advice reflected local customs, and all food
items were purchased by the subjects themselves. The
dietary instructions were reinforced weekly. At each session,
the dietician and the participant rated compliance with the
dietary advice on a scale from 1 to 5, with perfect
compliance equal to 1.
A 3-day-weighed food record of two weekdays and one
weekend day was performed before the study and during the
last week of the intervention. One-day-weighed food records
were completed in the 2nd, 5th and 7th weeks. The dietary
records were analyzed using the food–nutrient database
routinely used in each center.
Anthropometry and metabolic rate
Body weights were measured on calibrated scales. Waist and
hip circumferences were measured with the participant
wearing only non-restrictive underwear. Body height was
measured with a calibrated stadiometer. The mean of three
measurements was recorded for each variable. Fat mass and
fat-free mass were assessed by multifrequency bioimpedance
(Bodystats; QuadScan 4000, Isle of Man, British Isles).
Resting metabolic rate was measured by ventilated hood
systems routinely used at each center, and a standardized
validation program was used to facilitate pooling of the
results from the different centers.
Biochemical analyses
Venous blood samples were drawn after an overnight fast of
12 h, following a 3-day period when subjects had been
instructed to avoid excessive physical activity or alcohol
consumption. Subjects rested in the supine position for
15 min before the procedure. Fasting plasma glucose and
lipid concentrations were measured with standard enzy-
matic techniques on a COBAS FARA centrifugal spectro-
photometer (Roche Diagnostica, Basel, Switzerland; glucose
HK 125, ABX Diagnostics, Montpellier, France; triglycerides,
Sigma, St Louis, MO, USA; total cholesterol, cholesterol 100,
ABX Diagnostics Montpellier France; HDL, HDL-C, Roche,
IN, USA). Fasting plasma LDL-cholesterol was calculated
using the formula of Friedewald et al.14 Fasting plasma
insulin concentration was measured with a double-antibody
radioimmunoassay (Insulin, RIA 100, Kabi-Pharmacia, Up-
psala, Sweden). All biochemical analyses were conducted
independently of the allocated intervention groups in core
facilities at the Department of Human Biology, Nutrition
Research Centre NUTRIM, Maastricht University, and Med-
ical Laboratories Dr Stein & colleagues, Mo¨nchengladbach,
Germany.
Statistical analysis
The primary outcomes were mean weight loss and propor-
tion of subjects who lost more than 10% of initial body
weight, but we also analyzed the proportion of subjects
who lost more than 5% of their initial body weight. The
weight loss was calculated as the difference between the
weight recorded immediately before randomization and the
weight at the completion of the intervention program.
Secondary outcomes were drop out, body composition, and
blood lipids, insulin and glucose. Baseline differences were
compared by an independent two-sample t-test. Differences
in the changes were compared by univariate General Linear
Models controlling for center and baseline value, and as
appropriate with gender as covariate. To analyze changes
within a group, paired samples t-tests were used. Variables
with skewed distributions were log-transformed, and dis-
tributions were described by mean and s.d.. Testing of
treatment effects on dichotomous outcomes (dropout rates
and weight loss exceeding 5 and 10% of body weight) was
performed by logistic regression allowing for both treat-
ments, gender and center effects and using a robust
estimation of the variance. Reasons for dropout were
compared by w2 test. The time courses of weight loss with
the two diets were compared by repeated measurement
analysis in General Linear Models. A thorough analysis of
the impact on the estimated effects of the dietary regimens
of the missing values, owing to the absence from some of
the scheduled visits at the clinics and dropout, was
conducted according to the methods recently suggested
by Gadbury et al.15 This involved multiple imputation of
the missing values and analysis by mixed linear models
based on the assumption that values missing at random
were conditional on the relevant observed values. In
addition, a sensitivity analysis based on the assumptions
of plausible deviant missing values in either direction of the
results obtained was conducted. The outcomes of these
analyses were essentially similar to those presented in the
results section, and did not change the basis of the
conclusions drawn from the results and are therefore not
shown (they can be obtained on request). Statistical
significance was set at Po0.05. The statistical software SPSS
version 11.5, SAS version 8.2 and Stata version 8.0 were
used.
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Results
The analyses were first conducted in men and women
separately, and the results were presented for each gender.
However, no significant differences in outcome were found
between the two genders, and they were therefore also
analyzed together.
Baseline characteristics and dropouts
The two groups were well matched at randomization
(Table 1). Seventy (18.3%) failed to complete the 10-week
high-fat intervention and only 53 (13.6%) failed to complete
the low-fat intervention (P¼0.001). Causes of dropout
between the two groups were not statistically different and
included change in personal circumstances, dislike of the
diet and emerging health problems unrelated to the treat-
ments. There were no clinically or statistically significant
differences with respect to the variables listed in Table 1
between the participants who completed and those who did
not, or between non-completers in the high- and the low-fat
groups. The time point and the weight lost at dropout were
not significantly different between the two groups.
Dietary intake
The self-reported, baseline dietary intake of the two groups
was similar (Table 2). The fat energy percent during the
interventions was within the targeted interval: 25% in the low-
fat group and 40% in the high-fat group with a group
difference of 16% (95% confidence interval (CI) 15–17%).
Energy intake decreased to a slightly lower level in the low-fat
group than in the high-fat group (P¼0.023). The fiber intake
was approximately 20% higher in the low-fat group than in
the high-fat group (Po0.001). The percentage of energy from
protein was slightly higher in the low fat diet, but total intake
was not different. There was no difference between the
compliance ratings for the two diets. The ratio of saturated
to monounsaturated to polyunsaturated fatty acids was
approximately 2:2:1 in the habitual diet and in the two
intervention diets.
Body weight and body composition
Mean weight loss was 6.9 kg in the low, and 6.6 kg in the
high-fat group with no group difference (mean 0.3 (95% CI
0.2 to 0.8) kg) (Table 3). The proportion of subjects who lost
more than 5% was, on the low-fat diet 72.0% (242/336), and
on the high-fat diet, 70.5% (220/312) (P¼0.67). The
proportion of subjects who lost 10% or more was greater in
the low (20.8%, n¼70) than in the high-fat group (14.7%,
Table 1 Baseline characteristics of subjects at randomization
High fat (n¼382) Low fat (n¼ 389)
Women
(n¼287)
Men (n¼95) Women
(n¼ 292)
Men (n¼ 97)
Age (years) 37 (8) 38 (8) 36 (8) 39 (7)
Body weight (kg) 97.3 (14.8) 111.6 (16.0) 96.7 (15.0) 110.6 (18.0)
Height (m) 1.65 (0.06) 1.79 (0.07) 1.64 (0.07) 1.78 (0.07)
BMI (kg/m2) 35.8 (5.0) 34.9 (4.5) 35.9 (4.9) 34.7 (5.1)
Fat-free mass (kg) 53.9 (5.6) 76.9 (6.9) 53.7 (5.7) 76.0 (7.9)
Fat mass (kg) 43.6 (11.1) 34.8 (10.7) 43.0 (11.1) 34.5 (11.9)
Body fat (%) 44.2 (5.1) 30.6 (5.1) 43.9 (5.0) 30.5 (5.6)
Waist
circumference (cm)
103.4 (11.9) 114.6 (11.6) 103.4 (12.2) 114.0 (12.5)
Hip circumference
(cm)
121.2 (10.5) 114.9 (8.0) 120.6 (10.5) 115.2 (9.8)
Resting metabolic
rate (kcal/day)
1740 (226) 2151 (323) 1744 (251) 2119 (304)
BMI¼body mass index. Values are means (s.d.).
Table 2 Compositions of the habitual diet, the low- and the high-fat diets of
the obese subjects
Habitual (n¼745a)
(562 women,
185 men)
High fat (n¼370a)b
(278 women,
92 men)
Low fat (n¼ 377a)b
(284 women,
93 men)
Energy intake (kcal/day)
Women 2029 (550) 1514 (258) 1447 (258)
Men 2675 (838) 1928 (312) 1900 (442)
All 2187 (691) 1620 (327) 1561 (371)c
% of total energy from fat
Women 36 (7) 40 (5) 24 (5)
Men 37 (8) 40 (6) 26 (5)
All 36 (8) 40 (5) 25 (5)c
% of total energy from carbohydrate
Women 46 (8) 43 (5) 57 (5)
Men 44 (9) 42 (6) 56 (6)
All 45 (9) 43 (5) 57 (6)c
% of total energy from protein
Women 17 (4) 17 (3) 18 (3)
Men 16 (3) 17 (2) 18 (2)
All 17 (4) 17 (3) 18 (3)c
% of total energy from alcohold
Women 1 (3) 0.1 (0.4) 0.2 (0.8)
Men 3 (5) 0.4 (1.1) 0.5 (1.5)
All 2 (4) 0.2 (0.7) 0.4 (2.0)c
Dietary fiber (g/day)
Women 17 (7) 18 (6) 22 (7)
Men 21 (9) 23 (7) 26 (9)
All 18 (8) 19 (7) 23 (8)c
The composition of the habitual diet is based on a mean of a 3-day-weighed
food record. The intervention diets are based on a mean of 1-day-weighed
food records conducted in the 2nd, 5th and 7th weeks and a 3-day-weighed
record in the last week of the 10-week intervention. Values are means (s.d.). aA
small proportion of subjects did not complete the dietary records. bAll values
for dietary intake during both interventions were statistically different from the
habitual values. cSignificantly different from the high-fat diet. dThe % of total
amount of energy from alcohol were non-normally distributed. The habitual
median and 5th and 95th percentiles were 0.0 (0.0–9.3) %. During the
intervention the % of total amount of energy from alcohol were 0.0 (0.0–1.3)
% in the high- versus 0.0 (0.0–2.3) % in the low-fat group. These values were
tested by non-parametric tests.
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n¼46; P¼ 0.02) (Figure 2). There was no difference in the
time course of weight loss during the 10 weeks between the
groups (Figure 3). The changes in fat-free mass, fat mass,
waist and hip circumference were not statistically different
between the groups. In the intention-to-treat analysis, based
on the principle of ‘last observation carried forward’ showed
there was a 6.1% reduction of body weight in the low-fat
group versus 5.4% in the high-fat group.
Plasma lipids, glucose and insulin
The reduction of mean fasting plasma total cholesterol was
7.4% in the low versus 5.3% in the high-fat group (mean
difference 2.2 (95% CI 0.4–4.0)%, P¼0.016) (Table 4).
Fasting plasma LDL-cholesterol was lowered by 7.8% in the
low versus 4.7% in the high-fat group (mean difference 3.3
(95% CI 0.8–5.8)%, P¼0.01). In the low-fat group, mean
fasting plasma HDL-cholesterol was reduced by 7.3%, and
by 2.4% in the high-fat group (mean difference 4.1 (95% CI
1.9–6.2)%, Po0.001). Mean fasting plasma triacylglycerol
was lowered by 4.8% in the low and by 16.7% in the high-fat
group (mean difference 5.7 (95% CI 0.5–11.8)%, P¼0.07).
There was no difference in the change between the two diets
Table 3 Baseline and 10-week measurements of body weight and body composition in subjects completing the intervention
High fat (235 women, 77 men)a Low fat (251 women, 85 men)a Difference in mean changeb
Baseline Decrease Baseline Decrease (95% CI)c
Body weight (kg)
Women 97.4 (14.9) 6.1 (3.4) 96.7 (15.2) 6.7 (3.1) F
Men 110.9 (14.7) 8.2 (3.4) 110.3 (17.6) 7.6 (4.0) F
All 100.7 (16.0) 6.6 (3.5) 100.2 (16.9) 6.9 (3.4) 0.3 (0.8 to 0.2)
BMI (kg/m2)
Women 35.8 (5.0) 2.2 (1.2) 35.8 (4.9) 2.5 (1.1) F
Men 34.9 (4.3) 2.6 (1.1) 34.5 (4.8) 2.4 (1.3) F
All 35.6 (4.9) 2.3 (1.2) 35.5 (4.9) 2.5 (1.2) 0.1 (0.4 to 0.04)
Fat mass (kg)
Women 43.6 (11.2) 4.9 (3.2) 43.1 (11.3) 5.4 (2.9) F
Men 34.7 (10.0) 5.5 (6.2) 33.9 (11.3) 5.5 (3.6) F
All 41.4 (11.6) 5.0 (4.1) 40.8 (12.0) 5.4 (3.1) 0.5 (1.0 to 0.1)
Fat-free mass (kg)
Women 54.0 (5.7) 1.3 (2.3) 53.6 (5.8) 1.3 (2.4) F
Men 76.3 (6.4) 2.8 (6.1) 76.3 (7.9) 2.0 (2.2) F
All 59.5 (11.3) 1.6 (3.7) 59.4 (11.7) 1.5 (2.3) 0.1 (0.3 to 0.6)
Waist circumference (cm)
Women 103.3 (12.1) 5.5 (4.6) 103.4 (12.3) 5.5 (7.0) F
Men 114.1 (10.4) 7.7 (3.9) 113.6 (12.3) 7.8 (4.6) F
All 106.0 (12.6) 6.0 (4.5) 105.9 (13.1) 6.1 (6.5) 0.1 (0.9 to 0.8)
Hip circumference (cm)
Women 121.0 (10.8) 4.5 (3.7) 120.5 (10.6) 5.2 (5.7) F
Men 114.1 (7.8) 4.3 (3.4) 114.8 (8.9) 4.1 (3.3) F
All 119.3 (10.5) 4.5 (3.6) 119.0 (10.5) 4.9 (5.2) 0.5 (1.2 to 0.2)
BMI¼body mass index; CI¼ confidence interval. Baseline values and decreases are means (s.d.). aDuring the study, 70 and 53 subjects dropped out of the high- and
low-fat group, respectively. bMean difference in change is calculated by subtracting the mean decrease in the high-fat group from the mean decrease in the low-fat
group. cThe 95% CIs are adjusted for center, gender and baseline value.
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Figure 2 Cumulative percentage weight loss during the 10-week interven-
tion for the 648 subjects completing the 10-week intervention. The black line
represents the low (n¼336) and the dotted line the high-fat diet (n¼312).
On the x-axis, 0 represents a weight increase, 1 represents a weight loss of
o1%, 2 represents a weight loss ofo2%, and so on. The vertical line indicates
the definition of the outcome of losing 410% of initial body weight, which
was significantly different in the two groups (P¼ 0.02).
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in LDL/HDL ratio (mean difference 0.02 (95% CI 0.09 to
0.11)%). Fasting plasma insulin and glucose concentrations
were lowered similarly by both diets.
Discussion
This 10-week randomized trial of two hypo-energetic diets
with either low- or high-fat content, involving 771 obese
subjects from eight centers in seven European countries,
demonstrates that the two diets were not very different in
producing a clinically significant weight loss in both women
and men. There were however, in the low-fat group, fewer
dropouts and a higher proportion of subjects who lost more
than 10% of their initial body weight, than in the high-fat
group. Fasting plasma total, LDL- and HDL-cholesterol were
lowered more in the low-fat group, whereas fasting plasma
insulin and glucose decreased equally in the two groups.
To minimize misreporting,16–18 we carefully trained sub-
jects in completing weighed food records. In order to prevent
bias introduced by the enthusiasm of the dietician providing
the intervention,8 careful attention was paid to standardiz-
ing the delivery method of the dietary programs.
Week Number
-6
0 1 2 3 4 5 6 7 8 9 10
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Figure 3 Mean weight change with 95% confidence interval for the 648
subjects completing the 10-week intervention on the low-fat diet (open
squares, n¼336) or the high-fat diet (filled squares, n¼312). In weeks 1–9,
the number of body weights recorded was less than 648.
Table 4 Baseline and 10-week measurements of fasting plasma variables in subjects completing the intervention
High fat (235 women, 77 men)a Low fat (251 women, 85 men)a Difference in mean changeb
Baseline Decrease Baseline Decrease (95% CIs)c
Plasma cholesterol (mmol/l)
Women 4.85 (0.93) 0.20 (0.54) 4.92 (0.87) 0.32 (0.61) F
Men 5.03 (0.92) 0.41 (0.57) 5.01 (0.83) 0.48 (0.68) F
All 4.90 (0.93) 0.25 (0.55) 4.94 (0.86) 0.36 (0.63) 0.10 (0.02 to 0.18)
Plasma triacylglycerol (mmol/l)d
Women 1.04 (0.83) 0.12 (0.67) 1.02 (0.52) 0.01 (0.39) F
Men 1.49 (0.91) 0.40 (0.79) 1.19 (0.55) 0.13 (0.43) F
All 1.15 (0.87) 0.19 (0.71) 1.06 (0.53) 0.04 (0.41) 0.09 (0.16 to (0.03))
Plasma LDL-cholesterol (mmol/l)
Women 3.24 (0.82) 0.11 (0.49) 3.28 (0.80) 0.21 (0.54) F
Men 3.41 (0.75) 0.24 (0.51) 3.53 (0.78) 0.42 (0.62) F
All 3.28 (0.81) 0.14 (0.50) 3.34 (0.80) 0.26 (0.57) 0.11 (0.03 to 0.18)
Plasma HDL-cholesterol (mmol/l)
Women 1.16 (0.30) 0.05 (0.17) 1.19 (0.31) 0.11 (0.18) F
Men 0.96 (0.22) 0.00 (0.14) 0.94 (0.21) 0.00 (0.14) F
All 1.11 (0.29) 0.04 (0.16) 1.12 (0.31) 0.08 (0.18) 0.04 (0.02 to 0.07)
Plasma insulin (mU/ml)d
Women 10.2 (6.8) 0.74 (6.1) 9.5 (5.0) 1.1 (4.1) F
Men 12.0 (5.7) 2.7 (5.1) 10.9 (7.2) 1.5 (6.7) F
All 10.7 (6.6) 1.2 (5.9) 9.9 (5.7) 1.2 (4.9) 0.3 (0.5 to 1.0)
Plasma glucose (mmol/l)
Women 5.32 (0.67) 0.07 (0.44) 5.29 (1.00) 0.11 (0.47) F
Men 5.74 (0.62) 0.37 (0.51) 5.71 (1.21) 0.17 (0.54) F
All 5.43 (0.68) 0.14 (0.48) 5.39 (1.07) 0.12 (0.49) 0.01 (0.08 to 0.05)
BMI¼body mass index; CI¼ confidence interval; HDL¼high-density lipoprotein; LDL¼ low-density lipoprotein. Baseline values and decreases are mean (s.d.).
aDuring the study, 70 and 53 subjects dropped out of the high- and low-fat group, respectively. bMean difference in change is calculated by subtracting the mean
decrease in the high-fat group from the mean decrease in the low-fat group. cThe 95% CIs are adjusted for center, gender and baseline value. dPlasma triacylglycerol
and plasma insulin were non-normally distributed. The baseline median and 5 and 95 percentiles for total plasma triacylglycerol were 0.92 (0.42–2.71) mmol/l in the
high-fat group versus 0.95 (0.46–2.05) mmol/l in the low-fat group and for plasma insulin 9.5 (2.7–21.2) mU/ml versus 8.6 (2.3–20.2) mU/ml, respectively.
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Based on the differences between fat and carbohydrate in
digestibility and thermogenic effect, and interactions be-
tween diet composition and exercise, it has been suggested
that low-fat diets are superior to higher fat diets in producing
a weight loss.19,20 Short-term test meal studies with calorie
for calorie comparisons suggest that carbohydrate is more
satiating than fat and that overeating may be more likely
with a high-fat diet because of the higher energy density and
greater sensory pleasure.21,22 The present study demonstrates
that these potential differences produced by energy-fixed
diets with various fat and carbohydrate contents do not
translate into overall weight loss differences, but may
contribute to explain why more subjects lost 410% of the
initial body weight in the low-fat group. However, it is
important to stress that the study duration of only 10 weeks
was relatively short in the course of a weight management
program, and diet palatability and tolerability might have
more important influence on weight loss outcome in long-
term studies.
Other studies suggest that diets high in protein and fat, but
with very low carbohydrate contents, might be more
satiating, and produce better weight loss than low-fat diets
with normal protein content.4 However, it is very likely that
the high protein content rather than the high-fat content is
responsible for the weight loss effect with these diets.7 Our
results suggest that a larger proportion of obese subjects
achieve a major weight loss, that is, more than 10%, and
fewer will drop out on the low-fat diet. This is in line with
previous ad libitum studies,4–6 and suggests that energy from
carbohydrate are slightly more satiating than those from fat
also under conditions with a fixed energy deficit.
We did find a slightly greater reduction in energy intake in
the low- compared with the moderate-fat group, which may
be attributed to a greater satiating effect of the low-fat diet.
The difference of 60 kcal/day during a 10-week period
corresponds to a difference in weight loss of B0.54 kg,23
which is within the 95% CI of the difference in weight loss
among completers (0.2–0.8 kg). The slightly lower weight
loss in the high-fat diet may also be explained by the
contrast with subjects’ expectations regarding dietary weight
loss regimens, and the challenge of providing an acceptable
high-fat diet. This may also explain the lower rate of dropout
in the low-fat diet group. In this study, a larger weight loss
has been achieved than in most other studies. The interven-
tion package included prescribed energy intake based upon
an individually measured resting metabolic rate in contrast
to others who used a fixed energy intake target.7,8 A tailored
dietary program was used, in contrast to one other study,
which used a limited menu cycle,6 and a high level of
support was offered to the subjects.
The effect of the diets on blood lipids was as expected from
other studies.8,24 The slight reduction observed in HDL-
cholesterol is very likely owing to the negative energy
balance at the time of measurement. The effect of diet per
se on HDL-cholesterol cannot be seen before the subject are
weight stable. In previous studies, the undesirable reduction
in HDL-cholesterol brought about by a low-fat diet had
returned to baseline concentration by 6 months.8 Other
studies with smaller subject numbers showed either a
limited7 or no effect.6 The decrease in the blood lipids is
primarily a result of the weight loss per se. The present study
additionally demonstrates that both diets have beneficial
effects on blood lipids.
This study shows that when intensive support is given,
dietary advice of a hypo-energetic high-fat diet adhered to
during 10 weeks is almost as effective as a low-fat diet in
producing weight loss. However, more subjects lost 410% of
initial body weight on the low fat diet and fewer dropped
out. Both diets produced beneficial changes in the fasting
blood lipid profile, plasma insulin and glucose.
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